230 related articles for article (PubMed ID: 23660006)
1. [Practical guidelines for diagnosis and treatment of acromegaly. Grupo de Neuroendocrinología de la Sociedad Española de Endocrinología y Nutrición].
Cordido F; García Arnés JA; Marazuela Aspiroz M; Torres Vela E;
Endocrinol Nutr; 2013 Oct; 60(8):457.e1-457.e15. PubMed ID: 23660006
[No Abstract] [Full Text] [Related]
2. [Epidemiology of acromegaly in Spain].
Sesmilo G
Endocrinol Nutr; 2013 Oct; 60(8):470-4. PubMed ID: 23246411
[TBL] [Abstract][Full Text] [Related]
3. Medical progress: Acromegaly.
Melmed S
N Engl J Med; 2006 Dec; 355(24):2558-73. PubMed ID: 17167139
[No Abstract] [Full Text] [Related]
4. Twelve years of the Spanish acromegaly registry: a historical view of acromegaly management in Spain.
Sesmilo G; Webb SM;
Endocrinol Nutr; 2010 Feb; 57(2):39-42. PubMed ID: 20189894
[No Abstract] [Full Text] [Related]
5. Current pharmacotherapy for acromegaly: a review.
Biermasz NR; Romijn JA; Pereira AM; Roelfsema F
Expert Opin Pharmacother; 2005 Nov; 6(14):2393-405. PubMed ID: 16259571
[TBL] [Abstract][Full Text] [Related]
6. [Abnormalities of carbohydrate metabolism in acromegaly].
Biagetti B; Obiols G; Valladares S; Arnez L; Dalama B; Mesa J
Med Clin (Barc); 2013 Nov; 141(10):442-6. PubMed ID: 24012444
[TBL] [Abstract][Full Text] [Related]
7. [Optimization of the medical treatment for acromegaly].
Díez JJ; Iglesias P
Med Clin (Barc); 2013 Apr; 140(8):360-5. PubMed ID: 23103101
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of pituitary adenomas].
Mezosi E; Nemes O
Orv Hetil; 2009 Sep; 150(39):1803-10. PubMed ID: 19758960
[TBL] [Abstract][Full Text] [Related]
9. Pegvisomant: Balance after 10 years.
Bernabeu I; Marazuela M
Endocrinol Nutr; 2015 Oct; 62(8):363-5. PubMed ID: 26242927
[No Abstract] [Full Text] [Related]
10. Review of current and emerging treatment options in acromegaly.
Muhammad A; van der Lely AJ; Neggers SJ
Neth J Med; 2015 Oct; 73(8):362-7. PubMed ID: 26478545
[TBL] [Abstract][Full Text] [Related]
11. [Therapeutic strategies in somatotroph adenomas with extrasellar extension: role of the medical approach, a consensus study of the French Acromegaly Registry].
Jaquet P; Cortet-Rudelli Ch; Sassolas G; Morange-Ramos I; Chanson P; Brue T; Andrieu JM; Beckers A; Bertherat J; Borson-Chazot F; Brassier G; Caron P; Cogne M; Cottier JP; Delemer B; Dufour H; Enjalbert A; Figarella-Branger D; Gaillard R; Gueydan M; Jan M; Kuhn JM; Raingeard I; Regis J; Roger P; Rohmer V; Sadoul JL; Saveanu A; Tabarin A; Travers N; Trouillas J;
Ann Endocrinol (Paris); 2003 Dec; 64(6):434-41. PubMed ID: 15067248
[TBL] [Abstract][Full Text] [Related]
12. Management of endocrine disease: GH excess: diagnosis and medical therapy.
Andersen M
Eur J Endocrinol; 2014 Jan; 170(1):R31-41. PubMed ID: 24144967
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology of acromegaly in Ecuador.
López Gavilanez E; Guerrero Franco K; Solórzano Zambrano N; Navarro Chávez M; López Estrella C; Vaca Burbano L; Marriott Díaz E
Endocrinol Nutr; 2016; 63(7):333-8. PubMed ID: 27158065
[TBL] [Abstract][Full Text] [Related]
14. Cytoplasmic expression of SSTR2 and 5 by immunohistochemistry and by RT/PCR is not associated with the pharmacological response to octreotide.
Gonzalez B; Vargas G; Ramirez C; Asa S; Cheng S; Sandoval C; Mercado M
Endocrinol Nutr; 2014 Dec; 61(10):523-30. PubMed ID: 25008035
[TBL] [Abstract][Full Text] [Related]
15. Tight control of growth hormone: an attainable outcome for acromegaly treatment.
Melmed S
J Clin Endocrinol Metab; 1998 Oct; 83(10):3409-10. PubMed ID: 9768639
[No Abstract] [Full Text] [Related]
16. [Therapeutic management of acromegaly].
Metzner C; Hadziselimovic S; Grafe I; Nawroth P; Kasperk C
Med Klin (Munich); 2006 Jan; 101(1):15-23. PubMed ID: 16418810
[TBL] [Abstract][Full Text] [Related]
17. Pituitary tumor transforming gene and insulin-like growth factor 1 receptor expression and immunohistochemical measurement of Ki-67 as potential prognostic markers of pituitary tumors aggressiveness.
Sánchez-Tejada L; Sánchez-Ortiga R; Moreno-Pérez O; Montañana CF; Niveiro M; Tritos NA; Alfonso AM
Endocrinol Nutr; 2013; 60(7):358-67. PubMed ID: 23416216
[TBL] [Abstract][Full Text] [Related]
18. [Outcome of somatostatin analogue treatment in acromegaly].
Mondok A; Tóth M; Patócs A; Szücs N; Igaz P; Pusztai P; Czirják S; Beko G; Gláz E; Rácz K; Tulassay Z
Orv Hetil; 2009 Aug; 150(31):1457-62. PubMed ID: 19617182
[TBL] [Abstract][Full Text] [Related]
19. The treatment algorithm of acromegaly.
Colao A; Pivonello R; Cappabianca P; Vitale G; Lombardi G
J Endocrinol Invest; 2003; 26(8 Suppl):39-45. PubMed ID: 15233211
[No Abstract] [Full Text] [Related]
20. The multimodal treatment of acromegaly: current status and future perspectives.
Espinosa E; Ramirez C; Mercado M
Endocr Metab Immune Disord Drug Targets; 2014; 14(3):169-81. PubMed ID: 24915854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
